Improving tissue healing with engineered biomaterials that control protein delivery
Modulating Protein Activity in Tissue Repair using Engineered Affinity-based Biomaterials
This study is exploring new materials that can help deliver healing proteins more effectively to injured areas in the body, which could lead to better recovery for patients with injuries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oregon NIH-funded |
| Lab location | 1 site (Eugene, United States) |
| Project ID | NIH-11075821 on NIH RePORTER |
What this research studies
This research focuses on developing advanced biomaterials that can precisely control the delivery of multiple proteins to enhance tissue repair. By utilizing affinity-based interactions, these biomaterials aim to improve the timing and presentation of proteins at injury sites, which is crucial for effective healing. The project investigates how these interactions influence protein release and activity, ultimately aiming to optimize the healing process. Patients may benefit from new treatments that utilize these innovative materials to promote better recovery from injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals recovering from tissue injuries, particularly those involving bone or complex tissue damage.
Not a fit: Patients with non-tissue injury related conditions or those not requiring tissue repair may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for tissue injuries, improving healing outcomes for patients.
How similar studies have performed: Other research has shown promise in using engineered biomaterials for protein delivery, indicating potential success for this innovative approach.
Where this research is happening
Eugene, United States
- University of Oregon — Eugene, United States (Active)
Researchers
- Principal investigator: Hettiaratchi, Marian Hirushika — University of Oregon
- Study coordinator: Hettiaratchi, Marian Hirushika
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.